Middle East & Africa Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Middle East & Africa antimicrobial surgical suture market size is expected to reach US$ 18.07 million by 2031 from US$ 10.80 million in 2023. The market is estimated to record a CAGR of 6.7% from 2024-2031.

Executive Summary and Middle East & Africa Antimicrobial Surgical Suture Market Analysis:

The UAE, Saudi Arabia, and South Africa are the three major countries in the Middle East and Southern Africa. Saudi Arabia was this region's largest antimicrobial surgical suture market in 2023. The market for antimicrobial surgical sutures in the Middle East & Africa is anticipated to register a CAGR of 6.7% during the forecast period. Factors such as the increasing number of plastic surgeries, the growing prevalence of cervical cancer, and the rising surgical treatments for diseases are driving the Middle East & Africa antimicrobial surgical suture market .

Middle East & Africa Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the Middle East & Africa antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the Middle East & Africa antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the Middle East & Africa antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the Middle East & Africa antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

Middle East & Africa Antimicrobial Surgical Suture Market Outlook

Antimicrobial surgical suture holds tremendous potential in the surgical treatments of various ailments owing to their ability to prevent surgical site infections, which are common and one of the common causes of morbidity in postoperative setups. A few of the recent strategic initiatives by antimicrobial surgical suture market players are mentioned below.

In July 2022, Dolphin Sutures launched its Antibacterials range of antibacterial sutures containing Triclosan coating, which is a known broad-spectrum antibacterial and antifungal agent. In May 2022, Ethicon, Inc., a Johnson & Johnson Company, filed 510(K) to receive premarket approval for PDS Plus Antibacterial (Polydioxanone) Sterile Synthetic Absorbable Surgical Suture. Thus, continuous advancements in surgical sutures with product developments, innovations, product launches, product approvals, mergers, acquisitions, and partnerships are expected to present significant growth opportunities in the antimicrobial surgical suture market growth in the coming years.

Middle East & Africa Antimicrobial Surgical Suture Market Country Insights

Based on country, the Middle East & Africa antimicrobial surgical suture market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest share in 2023.

Government support for the healthcare industry has been a significant driver, with initiatives such as the Saudi Vision 2030 prioritizing investments in healthcare infrastructure and innovative medical technologies, including antimicrobial sutures. Technological advancements have also played a crucial role in the market growth, with the adoption of advanced suture materials and technologies, such as triclosan-coated sutures. The increasing incidence of surgical site infections (SSIs) and antibiotic-resistant bacteria in Saudi healthcare settings has fueled the demand for effective infection prevention solutions such as antimicrobial sutures. The Saudi Ministry of Health's guidelines and recommendations for infection control and prevention have emphasized the importance of antimicrobial sutures, driving their adoption among healthcare providers. The country's growing healthcare sector, driven by a large and aging population and increasing healthcare expenditure, has also contributed to the growth of the antimicrobial surgical sutures market in Saudi Arabia.

Middle East & Africa Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Boz Medical; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Product Code: BMIRE00031800

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Middle East & Africa Antimicrobial Surgical Suture Market - Key Market Dynamics

4.1 Market Drivers:
- 4.1.1 Surging Prevalence of Surgical Site Infections
- 4.1.2 Increasing Cases of Chronic Wounds and Surgeries
4.2 Market Restraints
- 4.2.1 Non-invasive Alternatives to Stitches
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
4.4 Future Trends
- 4.4.1 Smart Antimicrobial Sutures
4.5 Impact of Drivers and Restraints:

5. Antimicrobial Surgical Suture Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
5.2 Middle East & Africa Antimicrobial Surgical Suture Market Forecast Analysis

6. Middle East & Africa Antimicrobial Surgical Suture Market Analysis - by Type

6.1 Triclosan Antimicrobial Suture
- 6.1.1 Overview
- 6.1.2 Triclosan Antimicrobial Suture: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Chlorhexidine Antimicrobial Suture
- 6.2.1 Overview
- 6.2.2 Chlorhexidine Antimicrobial Suture: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

7. Middle East & Africa Antimicrobial Surgical Suture Market Analysis - by Raw Materials

7.1 Polyglactin 910 Antimicrobial Suture
- 7.1.1 Overview
- 7.1.2 Polyglactin 910 Antimicrobial Suture: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Poliglecaprone 25
- 7.2.1 Overview
- 7.2.2 Poliglecaprone 25: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Polyglycolic Acid
- 7.3.1 Overview
- 7.3.2 Polyglycolic Acid: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Antimicrobial Surgical Suture Market Analysis - by Application

8.1 Cardiovascular Surgery
- 8.1.1 Overview
- 8.1.2 Cardiovascular Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.2 General Surgery
- 8.2.1 Overview
- 8.2.2 General Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Ophthalmic Surgery
- 8.3.1 Overview
- 8.3.2 Ophthalmic Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Gynaecological Surgery
- 8.4.1 Overview
- 8.4.2 Gynaecological Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Orthopedic Surgery
- 8.5.1 Overview
- 8.5.2 Orthopedic Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Plastic Surgery
- 8.6.1 Overview
- 8.6.2 Plastic Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Veterinary Surgery
- 8.7.1 Overview
- 8.7.2 Veterinary Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Dental Surgery
- 8.8.1 Overview
- 8.8.2 Dental Surgery: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. Middle East & Africa Antimicrobial Surgical Suture Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. Middle East & Africa Antimicrobial Surgical Suture Market - Country Analysis

10.1 Middle East & Africa
- 10.1.1 Middle East & Africa Antimicrobial Surgical Suture Market Overview
- 10.1.2 Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 Saudi Arabia: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 Saudi Arabia: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.1.2 Saudi Arabia: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.1.3 Saudi Arabia: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.1.4 Saudi Arabia: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.2 South Africa: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 South Africa: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.2.2 South Africa: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.2.3 South Africa: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.2.4 South Africa: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.3 United Arab Emirates: Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 United Arab Emirates: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.3.2 United Arab Emirates: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.3.3 United Arab Emirates: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.3.4 United Arab Emirates: Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.4 Rest of Middle East & Africa Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Rest of Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.4.2 Rest of Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.4.3 Rest of Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.4.4 Rest of Middle East & Africa Antimicrobial Surgical Suture Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies
- 11.2.1 Overview
11.3 Company Market Share Analysis (%), 2023

12. Company Profiles

12.1 TI Medical
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Healthium Medtech Limited
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Meril Life Sciences Pvt Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Unilene
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Johnson & Johnson
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Futura Surgicare Pvt Ltd (Dolphin Sutures)
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Advanced MedTech Solutions Pvt. Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Internacional Farmaceutica SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms